1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Leishmaniasis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Meglumine Antimoniate 1.2.3 Pentamidine 1.2.4 Hydroxyl Amidine Stilbene 1.2.5 Amphotericin B 1.3 Market by Application 1.3.1 Global Leishmaniasis Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Visceral Leishmaniasis 1.3.3 Cutaneous Leishmaniasis 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Leishmaniasis Treatment Market Perspective (2016-2027) 2.2 Leishmaniasis Treatment Growth Trends by Regions 2.2.1 Leishmaniasis Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Leishmaniasis Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Leishmaniasis Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Leishmaniasis Treatment Industry Dynamic 2.3.1 Leishmaniasis Treatment Market Trends 2.3.2 Leishmaniasis Treatment Market Drivers 2.3.3 Leishmaniasis Treatment Market Challenges 2.3.4 Leishmaniasis Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Leishmaniasis Treatment Players by Revenue 3.1.1 Global Top Leishmaniasis Treatment Players by Revenue (2016-2021) 3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Leishmaniasis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Leishmaniasis Treatment Revenue 3.4 Global Leishmaniasis Treatment Market Concentration Ratio 3.4.1 Global Leishmaniasis Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Leishmaniasis Treatment Revenue in 2020 3.5 Leishmaniasis Treatment Key Players Head office and Area Served 3.6 Key Players Leishmaniasis Treatment Product Solution and Service 3.7 Date of Enter into Leishmaniasis Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Leishmaniasis Treatment Breakdown Data by Type 4.1 Global Leishmaniasis Treatment Historic Market Size by Type (2016-2021) 4.2 Global Leishmaniasis Treatment Forecasted Market Size by Type (2022-2027) 5 Leishmaniasis Treatment Breakdown Data by Application 5.1 Global Leishmaniasis Treatment Historic Market Size by Application (2016-2021) 5.2 Global Leishmaniasis Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Leishmaniasis Treatment Market Size (2016-2027) 6.2 North America Leishmaniasis Treatment Market Size by Type 6.2.1 North America Leishmaniasis Treatment Market Size by Type (2016-2021) 6.2.2 North America Leishmaniasis Treatment Market Size by Type (2022-2027) 6.2.3 North America Leishmaniasis Treatment Market Size by Type (2016-2027) 6.3 North America Leishmaniasis Treatment Market Size by Application 6.3.1 North America Leishmaniasis Treatment Market Size by Application (2016-2021) 6.3.2 North America Leishmaniasis Treatment Market Size by Application (2022-2027) 6.3.3 North America Leishmaniasis Treatment Market Size by Application (2016-2027) 6.4 North America Leishmaniasis Treatment Market Size by Country 6.4.1 North America Leishmaniasis Treatment Market Size by Country (2016-2021) 6.4.2 North America Leishmaniasis Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Leishmaniasis Treatment Market Size (2016-2027) 7.2 Europe Leishmaniasis Treatment Market Size by Type 7.2.1 Europe Leishmaniasis Treatment Market Size by Type (2016-2021) 7.2.2 Europe Leishmaniasis Treatment Market Size by Type (2022-2027) 7.2.3 Europe Leishmaniasis Treatment Market Size by Type (2016-2027) 7.3 Europe Leishmaniasis Treatment Market Size by Application 7.3.1 Europe Leishmaniasis Treatment Market Size by Application (2016-2021) 7.3.2 Europe Leishmaniasis Treatment Market Size by Application (2022-2027) 7.3.3 Europe Leishmaniasis Treatment Market Size by Application (2016-2027) 7.4 Europe Leishmaniasis Treatment Market Size by Country 7.4.1 Europe Leishmaniasis Treatment Market Size by Country (2016-2021) 7.4.2 Europe Leishmaniasis Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Leishmaniasis Treatment Market Size (2016-2027) 8.2 Asia-Pacific Leishmaniasis Treatment Market Size by Type 8.2.1 Asia-Pacific Leishmaniasis Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Leishmaniasis Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Leishmaniasis Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Leishmaniasis Treatment Market Size by Application 8.3.1 Asia-Pacific Leishmaniasis Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Leishmaniasis Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Leishmaniasis Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Leishmaniasis Treatment Market Size by Region 8.4.1 Asia-Pacific Leishmaniasis Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Leishmaniasis Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Leishmaniasis Treatment Market Size (2016-2027) 9.2 Latin America Leishmaniasis Treatment Market Size by Type 9.2.1 Latin America Leishmaniasis Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Leishmaniasis Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Leishmaniasis Treatment Market Size by Type (2016-2027) 9.3 Latin America Leishmaniasis Treatment Market Size by Application 9.3.1 Latin America Leishmaniasis Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Leishmaniasis Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Leishmaniasis Treatment Market Size by Application (2016-2027) 9.4 Latin America Leishmaniasis Treatment Market Size by Country 9.4.1 Latin America Leishmaniasis Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Leishmaniasis Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Leishmaniasis Treatment Market Size (2016-2027) 10.2 Middle East & Africa Leishmaniasis Treatment Market Size by Type 10.2.1 Middle East & Africa Leishmaniasis Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Leishmaniasis Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Leishmaniasis Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Leishmaniasis Treatment Market Size by Application 10.3.1 Middle East & Africa Leishmaniasis Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Leishmaniasis Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Leishmaniasis Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Leishmaniasis Treatment Market Size by Country 10.4.1 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck Leishmaniasis Treatment Introduction 11.1.4 Merck Revenue in Leishmaniasis Treatment Business (2016-2021) 11.1.5 Merck Recent Development 11.2 iCo Therapeutics 11.2.1 iCo Therapeutics Company Details 11.2.2 iCo Therapeutics Business Overview 11.2.3 iCo Therapeutics Leishmaniasis Treatment Introduction 11.2.4 iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2016-2021) 11.2.5 iCo Therapeutics Recent Development 11.3 AEterna Zentaris 11.3.1 AEterna Zentaris Company Details 11.3.2 AEterna Zentaris Business Overview 11.3.3 AEterna Zentaris Leishmaniasis Treatment Introduction 11.3.4 AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2016-2021) 11.3.5 AEterna Zentaris Recent Development 11.4 AEterna Zentaris AG 11.4.1 AEterna Zentaris AG Company Details 11.4.2 AEterna Zentaris AG Business Overview 11.4.3 AEterna Zentaris AG Leishmaniasis Treatment Introduction 11.4.4 AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2016-2021) 11.4.5 AEterna Zentaris AG Recent Development 11.5 Eurofins Advinus 11.5.1 Eurofins Advinus Company Details 11.5.2 Eurofins Advinus Business Overview 11.5.3 Eurofins Advinus Leishmaniasis Treatment Introduction 11.5.4 Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2016-2021) 11.5.5 Eurofins Advinus Recent Development 11.6 Pieris Pharmaceuticals 11.6.1 Pieris Pharmaceuticals Company Details 11.6.2 Pieris Pharmaceuticals Business Overview 11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Introduction 11.6.4 Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2016-2021) 11.6.5 Pieris Pharmaceuticals Recent Development 11.7 Dafra Pharma 11.7.1 Dafra Pharma Company Details 11.7.2 Dafra Pharma Business Overview 11.7.3 Dafra Pharma Leishmaniasis Treatment Introduction 11.7.4 Dafra Pharma Revenue in Leishmaniasis Treatment Business (2016-2021) 11.7.5 Dafra Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Leishmaniasis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Meglumine Antimoniate Table 3. Key Players of Pentamidine Table 4. Key Players of Hydroxyl Amidine Stilbene Table 5. Key Players of Amphotericin B Table 6. Global Leishmaniasis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Leishmaniasis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Leishmaniasis Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Leishmaniasis Treatment Market Share by Regions (2016-2021) Table 10. Global Leishmaniasis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Leishmaniasis Treatment Market Share by Regions (2022-2027) Table 12. Leishmaniasis Treatment Market Trends Table 13. Leishmaniasis Treatment Market Drivers Table 14. Leishmaniasis Treatment Market Challenges Table 15. Leishmaniasis Treatment Market Restraints Table 16. Global Leishmaniasis Treatment Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Leishmaniasis Treatment Market Share by Players (2016-2021) Table 18. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leishmaniasis Treatment as of 2020) Table 19. Ranking of Global Top Leishmaniasis Treatment Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Leishmaniasis Treatment Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Leishmaniasis Treatment Product Solution and Service Table 23. Date of Enter into Leishmaniasis Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 26. Global Leishmaniasis Treatment Revenue Market Share by Type (2016-2021) Table 27. Global Leishmaniasis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Leishmaniasis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Leishmaniasis Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Leishmaniasis Treatment Revenue Market Share by Application (2016-2021) Table 31. Global Leishmaniasis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Leishmaniasis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 34. North America Leishmaniasis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Leishmaniasis Treatment Market Size by Application (2016-2021) (US$ Million) Table 36. North America Leishmaniasis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Leishmaniasis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Leishmaniasis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Leishmaniasis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Leishmaniasis Treatment Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Leishmaniasis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Leishmaniasis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Leishmaniasis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Leishmaniasis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Leishmaniasis Treatment Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Leishmaniasis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Leishmaniasis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Leishmaniasis Treatment Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Leishmaniasis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Leishmaniasis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Leishmaniasis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Leishmaniasis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Leishmaniasis Treatment Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Leishmaniasis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 63. Merck Company Details Table 64. Merck Business Overview Table 65. Merck Leishmaniasis Treatment Product Table 66. Merck Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million) Table 67. Merck Recent Development Table 68. iCo Therapeutics Company Details Table 69. iCo Therapeutics Business Overview Table 70. iCo Therapeutics Leishmaniasis Treatment Product Table 71. iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million) Table 72. iCo Therapeutics Recent Development Table 73. AEterna Zentaris Company Details Table 74. AEterna Zentaris Business Overview Table 75. AEterna Zentaris Leishmaniasis Treatment Product Table 76. AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million) Table 77. AEterna Zentaris Recent Development Table 78. AEterna Zentaris AG Company Details Table 79. AEterna Zentaris AG Business Overview Table 80. AEterna Zentaris AG Leishmaniasis Treatment Product Table 81. AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million) Table 82. AEterna Zentaris AG Recent Development Table 83. Eurofins Advinus Company Details Table 84. Eurofins Advinus Business Overview Table 85. Eurofins Advinus Leishmaniasis Treatment Product Table 86. Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million) Table 87. Eurofins Advinus Recent Development Table 88. Pieris Pharmaceuticals Company Details Table 89. Pieris Pharmaceuticals Business Overview Table 90. Pieris Pharmaceuticals Leishmaniasis Treatment Product Table 91. Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million) Table 92. Pieris Pharmaceuticals Recent Development Table 93. Dafra Pharma Company Details Table 94. Dafra Pharma Business Overview Table 95. Dafra Pharma Leishmaniasis Treatment Product Table 96. Dafra Pharma Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million) Table 97. Dafra Pharma Recent Development Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Global Leishmaniasis Treatment Market Share by Type: 2020 VS 2027 Figure 2. Meglumine Antimoniate Features Figure 3. Pentamidine Features Figure 4. Hydroxyl Amidine Stilbene Features Figure 5. Amphotericin B Features Figure 6. Global Leishmaniasis Treatment Market Share by Application: 2020 VS 2027 Figure 7. Visceral Leishmaniasis Case Studies Figure 8. Cutaneous Leishmaniasis Case Studies Figure 9. Leishmaniasis Treatment Report Years Considered Figure 10. Global Leishmaniasis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Leishmaniasis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Leishmaniasis Treatment Market Share by Regions: 2020 VS 2027 Figure 13. Global Leishmaniasis Treatment Market Share by Regions (2022-2027) Figure 14. Global Leishmaniasis Treatment Market Share by Players in 2020 Figure 15. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leishmaniasis Treatment as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Leishmaniasis Treatment Revenue in 2020 Figure 17. Global Leishmaniasis Treatment Revenue Market Share by Type (2016-2021) Figure 18. Global Leishmaniasis Treatment Revenue Market Share by Type (2022-2027) Figure 19. North America Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Leishmaniasis Treatment Market Share by Type (2016-2027) Figure 21. North America Leishmaniasis Treatment Market Share by Application (2016-2027) Figure 22. North America Leishmaniasis Treatment Market Share by Country (2016-2027) Figure 23. United States Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Leishmaniasis Treatment Market Share by Type (2016-2027) Figure 27. Europe Leishmaniasis Treatment Market Share by Application (2016-2027) Figure 28. Europe Leishmaniasis Treatment Market Share by Country (2016-2027) Figure 29. Germany Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Leishmaniasis Treatment Market Share by Type (2016-2027) Figure 37. Asia-Pacific Leishmaniasis Treatment Market Share by Application (2016-2027) Figure 38. Asia-Pacific Leishmaniasis Treatment Market Share by Region (2016-2027) Figure 39. China Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Leishmaniasis Treatment Market Share by Type (2016-2027) Figure 47. Latin America Leishmaniasis Treatment Market Share by Application (2016-2027) Figure 48. Latin America Leishmaniasis Treatment Market Share by Country (2016-2027) Figure 49. Mexico Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Leishmaniasis Treatment Market Share by Type (2016-2027) Figure 53. Middle East & Africa Leishmaniasis Treatment Market Share by Application (2016-2027) Figure 54. Middle East & Africa Leishmaniasis Treatment Market Share by Country (2016-2027) Figure 55. Turkey Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Merck Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021) Figure 59. iCo Therapeutics Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021) Figure 60. AEterna Zentaris Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021) Figure 61. AEterna Zentaris AG Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021) Figure 62. Eurofins Advinus Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021) Figure 63. Pieris Pharmaceuticals Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021) Figure 64. Dafra Pharma Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Merck iCo Therapeutics AEterna Zentaris AEterna Zentaris AG Eurofins Advinus Pieris Pharmaceuticals Dafra Pharma